• Leerink Partnrs Comments on Tourmaline Bio FY2029 Earnings

    Source: Buzz FX / 08 Feb 2025 07:41:11   America/Chicago


    Leerink Partnrs Comments on Tourmaline Bio FY2029 Earnings Written by MarketBeat February 8, 2025 Share Link copied to clipboard.
    Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals Tourmaline Bio, Inc.
    Read more...
Share on,